Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program...
8 insider purchases on record · latest filing 2023-04-24.
Insiders have also filed 2 sale transactions at GNPX.